ArticleJournal of vitreoretinal diseases2026
Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.
Sean T Berkowitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.